Dr. Steven A. Madreperla joined NJRetina in 1999. He then earned his MD/PhD (Neuroscience) degree from Johns Hopkins University School of Medicine, Baltimore and completed his residency in ophthalmology at the Wilmer Ophthalmological Institute at Johns Hopkins. His fellowship training in vitreoretinal disease and surgery was completed at the Duke University Eye Center, Raleigh, followed by an additional fellowship in Ocular Oncology at the Moorfields Eye Hospital, St. Bartholomew’s Hospital, London.
Dr. Madreperla holds teaching appointments at the Rutgers-New Jersey Medical School. He is on the medical staff of Clara Maass Medical Center, St. Barnabas Medical Center, Hackensack University Medical Center, and the University of Medicine of Dentistry of New Jersey.
Dr. Madreperla has researched, published, and lectured at national and international meetings on numerous topics in ophthalmology, including diabetic retinopathy, macular degeneration, retinoblastoma, choroidal hemangioma, choroidal melanoma, macular hole, and retinitis pigmentosa. Dr. Madreperla has extensive participation as Principal Investigator in a number of multi-center clinical trials for macular degeneration, diabetic macular edema, and retinal vein occlusion.
Dr. Madreperla is the President of NJRetina and the CEO and President of PRISM vision group.
Dr. Madreperla is married with two children, and he enjoys golf, fishing, and aviation.